J2KBIO Co., Ltd. (KOSDAQ:420570)
8,310.00
-140.00 (-1.66%)
At close: Apr 28, 2026
J2KBIO Revenue
In the year 2025, J2KBIO had annual revenue of 32.97B KRW, down -0.49%. J2KBIO had revenue of 8.61B in the quarter ending December 31, 2025, with 27.22% growth.
Revenue
32.97B
Revenue Growth
-0.49%
P/S Ratio
1.49
Revenue / Employee
610.49M
Employees
54
Market Cap
49.06B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ADBiotech | 12.90B |
| Parataxis Korea | 9.00M |
| Poongjeon Pharmacy CO.,LTD. | 1.54B |
| EyeGene | 3.57B |
| MOA Life Plus | 11.22B |
| Kainos Medicine | 1.17B |
| Eutilex.Co.,Ltd | 10.29B |
| HLB Pep | 4.96B |